{"database": "openregs", "table": "documents", "rows": [["CMS-2023-0146-0001", "CMS", "CMS-2023-0146", "Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer\u2019s Disease (CMS\u201310865)", "Notice", null, "2023-09-07T04:00:00Z", 2023, 9, "2023-09-07T04:00:00Z", "2023-11-07T04:59:59Z", "2023-09-07T19:04:25Z", "2023-19211", 0, 0, "0900006485f53965"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["CMS-2023-0146-0001"], "units": {}, "query_ms": 0.629157992079854, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}